Roivant Sciences Ltd. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Roivant Sciences Ltd. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2020 to Q2 2024.
  • Roivant Sciences Ltd. Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2024 was -$661M, a 8935% decline year-over-year.
  • Roivant Sciences Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $419M, a 16% decline from 2022.
  • Roivant Sciences Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $499M, a 62.8% increase from 2021.
  • Roivant Sciences Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $307M, a 32.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$661M -$668M -8935% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q2 2023 $7.48M -$134M -94.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q2 2022 $142M +$132M +1291% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q2 2021 $10.2M -$171M -94.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q2 2020 $181M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.